drugset / Trial / NCT00788242

The Effect of Glucose-Insulin-Potassium Infusion in Patients Undergoing Cardiac Surgery

NCT00788242

Completed 200 enrolled Christoph Ellenberger
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to evaluate the cardioprotective effects of a short term infusion of glucose-insulin-potassium (GIK) during heart surgery.

Timeline

Start
2009-01
Primary completion
2013-12
Completion
2013-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Glucose Unknown 40 %
Subject Insulin Protein / enzyme biologic 20 iu
Subject KCl Unknown 10 mmol